![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 33, 25188-25193, August 18, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry, Stanford University School of
Medicine, Stanford, California 94305-5307
Received for publication, February 10, 2000, and in revised form, May 26, 2000
TIP47 (tail-interacting
protein of 47 kDa) binds to the cytoplasmic
domains of the cation-independent and cation-dependent mannose 6-phosphate receptors and is required for their transport from
late endosomes to the trans Golgi network in vitro and
in vivo. We report here a quantitative analysis of the
interaction of recombinant TIP47 with mannose 6-phosphate receptor
cytoplasmic domains. Recombinant TIP47 binds more tightly to the
cation-independent mannose 6-phosphate receptor (KD = 1 µM) than to the cation-dependent mannose
6-phosphate receptor (KD = 3 µM). In
addition, TIP47 fails to interact with the cytoplasmic domains of the
hormone-processing enzymes, furin, phosphorylated furin, and
metallocarboxypeptidase D, as well as the cytoplasmic domain of TGN38,
proteins that are also transported from endosomes to the trans Golgi
network. Although these proteins failed to bind TIP47, furin and TGN38
were readily recognized by the clathrin adaptor, AP-2. These data
suggest that TIP47 recognizes a very select set of cargo molecules.
Moreover, our data suggest unexpectedly that furin, TGN38, and
carboxypeptidase D may use a distinct vesicular carrier and perhaps a
distinct route for transport between endosomes and the trans Golgi network.
Mannose 6-phosphate receptors
(MPRs)1 bind to newly
synthesized, soluble lysosomal enzymes and carry them from the Golgi
complex to prelysosomes (1). The low pH within this compartment leads to the release of the receptor-bound hydrolases; MPRs can then return
to the Golgi complex to initiate another round of lysosomal enzyme
delivery. Two MPRs have been described to date (2). One is a 300-kDa
transmembrane glycoprotein that also contains a high affinity binding
site for insulin-like growth factor II. This receptor is known as the
cation-independent MPR (CI-MPR) because it does not require divalent
cations for ligand binding in vitro. A second, smaller,
46-kDa MPR requires divalent cations for ligand binding and is referred
to as the cation-dependent MPR (CD-MPR). Both receptors
share common pathways of intracellular transport and bind to an
overlapping set of lysosomal enzymes (2).
We study the recycling of MPRs from endosomes back to the Golgi
complex. We have established a cell-free system that reconstitutes this
process in vitro (3, 4) and have identified a number of
proteins that are required for MPR recycling. The Rab9 GTPase (5), its
effector p40 (6), the NSF ATPase, its adaptor We recently discovered a protein named TIP47
(tail-interacting protein of
47 kDa) that binds to the cytoplasmic domains of the CI-
and CD-MPRs and is required for their recycling to the Golgi complex
both in vitro and in vivo (8). TIP47 recognizes a
Phe-Trp motif in the CD-MPR (8) that is required for retrieval of this
receptor from endosomes and diversion from lysosomes (9). It is not yet
known what TIP47 recognizes in the CI-MPR, which does not contain a
related, Phe-Trp motif. Nevertheless, TIP47 does not recognize tyrosine
or dileucine motifs in either the CD- or CI-MPRs (8), a feature that
distinguishes it from clathrin AP-1 and AP-2 adaptor complexes
(10).
In addition to MPRs, other proteins also cycle between endosomes and
the Golgi complex. For example, TGN38 is a ~90-kDa transmembrane glycoprotein of unknown function that is localized to the trans Golgi
network (11). Its 33-amino acid cytoplasmic domain contains the
sequence, YQRL that is essential for TGN localization (12-15). Although TGN38 is found predominantly in the TGN at steady state, the
protein cycles continuously between the cell surface, endosomes, and
the TGN (12, 16). Similarly, furin (17) and metallocarboxypeptidase D
(CPD) (18) are TGN-localized, membrane-bound enzymes that function in
the post-translational processing of secreted proteins. Like TGN38,
furin and CPD also appear to cycle with some frequency between the cell
surface, endosomes, and the TGN (17-21).
Since TIP47 recognizes MPRs and is required for their retrieval from
endosomes, we think of TIP47 as a cargo selection device for
endosome-to-Golgi transport. It was therefore of interest to determine
if TIP47 interacts with other proteins that traverse similar
intracellular transport pathways. We report here that TIP47 fails to
interact with the cytoplasmic domains of TGN38, furin, phosphorylated
furin, or CPD. These observations suggest that these proteins may
utilize a distinct type of transport vesicle for their transport from
endosomes to the Golgi complex.
His-tagged TIP47 was purified after expression in
Eschericha coli as described (8). Recombinant cytoplasmic
domains (GST-CI-MPR, GST-CI-MPR Y24A/Y26A/V29A, GST-CD-MPR,
GST-LDL receptor, GST-furin (gift of Gary Thomas, Vollum Institute,
Portland, OR), GST-carboxypeptidase (gift of Oleg Varlamov, Albert
Einstein University, New York), and GST-HIV-Nef (gift of Didier
Trono, University of Geneva)) were prepared and purified as described
(8) followed by S100 gel filtration chromatography. GST-TGN-38 (gift of
Sharon Milgram, University of North Carolina) was purified as follows.
Bacteria were lysed by incubation with lysozyme and 0.1% Triton X-100
(in HKE buffer (50 mM Hepes, pH 7.0, 100 mM
KCl, 2 mM EDTA)) (instead of a French press), and the
cleared lysate (100 ml) was loaded onto a 5-ml, SP-Sepharose cation
exchange resin. The resin was washed with 50 ml of HKE buffer without
Triton X-100 and eluted with 15 ml of 50 mM Hepes, pH 8.0, 1 M KCl, 2 mM EDTA, and 0.01% Triton X-100.
The eluate was applied onto 500 µl of glutathione-Sepharose with
recycling, and the column was washed with 50 ml of HKE, pH 8.0. GST-TGN38 was then eluted by resuspension in 2 × 1.25 ml of elution buffer (50 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 10 mM reduced glutathione) plus
0.01% Triton X-100. Glutathione was removed by passage over a
P6DG column (Bio-Rad) equilibrated in 25 mM Hepes, pH 7.5, 50 mM KCl, 1 mM MgCl2, 0.01%
Triton X-100. All protein preparations contained a small amount
of free GST; GST background was minimal and subtracted.
In Vitro Phosphorylation of GST-Furin--
Phosphorylation of
GST-furin was achieved by incubating GST-furin (20 µM),
ATP (200 µM), and casein kinase II (250 units/ml, New
England Biolabs, Beverly, MA) in 20 mM Tris-HCl, 50 mM KCl, and 10 mM MgCl2. The
reaction was incubated at 30 °C for 1 h, after which
glutathione-Sepharose was added to capture the GST-furin. With small
scale reactions, quantitation of [ Texas Red Fluorescent Labeling of TIP47--
Texas
Red® sulfonyl chloride (Molecular Probes, Inc., Eugene,
OR; 60 µl at 10 mg/ml in anhydrous dimethyl formamide), was
combined with 2 ml of ice-cold TIP47 (3 mg/ml in 25 mM
Hepes, pH 7.5). The reaction was mixed end-over-end for 45 min at
4 °C. Labeled TIP47 was subsequently purified on a Sepharose S-100
size exclusion column to remove unincorporated dye. Fractions
containing labeled TIP47 were pooled and analyzed for protein content;
Texas Red® content was determined by absorbance at 596 nm. The molar ratio of Texas Red® to TIP47 was calculated
to be 1.9.
Determination of Active Molecules and Calculation
Assumptions--
All of our calculations assume that His-tagged TIP47
has a monomeric molecular mass of 52 kDa. However, recombinant
TIP47 chromatographs as a somewhat heterodisperse oligomer (8); thus, all of our KD determinations may be underestimates
of the actual binding affinity. TIP47 protein binding capacity is highly dependent upon expression and storage conditions. Most active
preparations were obtained from cells induced to express the protein at
low cell densities (A600 = 0.1) and contained
glycerol during the purification and for storage. We estimate that
TIP47 preparations contain 10% active molecules as determined by the fraction that were capable of binding to saturating amounts of the
CI-MPR cytoplasmic domain. It is possible that the tendency of
recombinant TIP47 to oligomerize is responsible for the relatively low
recovery of active molecules. Nevertheless, we observe the same
selectivity for MPR wild type and mutant forms when partially purified,
native TIP47 is compared with the recombinant protein studied here.
Finally, Texas Red labeling does not influence the activity of our
preparation; control immunoblot experiments using unlabeled
recombinant TIP47 and assuming 10% active molecules yielded identical
KD values.
Fluorescent TIP47 Binding--
Binding was determined in 25 mM Hepes, pH 7.5, 150 mM KCl, 1 mM
MgCl2, and 1 mg/ml bovine serum albumin in a 500-µl total volume. Receptor cytoplasmic domain GST fusion proteins (0-15 µM) were mixed with TIP47 (50 nM active
protein) and incubated for 1 h at room temperature followed by the
addition of 50 µl of glutathione-Sepharose (1:1 slurry) for an
additional 45 min. The slurry was subsequently passed through an empty
1-ml column fitted with a porous support and washed rapidly with 1 ml
of binding buffer to remove unbound TIP47. GST fusion proteins were
eluted from glutathione-Sepharose by a 15-min incubation in 500 µl of elution buffer. The eluate was analyzed for fluorescent labeled TIP47
using Cytosolic TIP47 Binding--
Receptor cytoplasmic domain-GST
fusions (3.6 nmol) were mixed end-over-end with 950 µl of K562
cytosol (8.4 mg/ml) in 0.01% Triton X-100 plus 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 40 µg/ml
aprotinin, 1 µM pepstatin A for 90 min. Subsequently, 100 µl of glutathione-Sepharose beads (1:1 slurry) were added for another
60 min. Beads were pelleted at low speed and washed five times with 1 ml of HKE buffer (pH 8.0). Bound proteins were eluted by a 15-min
incubation of the beads in 100 µl of elution buffer containing 50 mM reduced glutathione. The elution was repeated, eluates
were combined, and 40 µl was analyzed by immunoblotting for TIP47.
AP-1 and AP-2 Binding--
Clathrin adaptors AP-1 and AP-2 were
purified from bovine brain clathrin-coated vesicles as described (22)
and purified to homogeneity using hydroxyapatite (23). AP-1 and AP-2
concentrations were determined as follows. Known amounts of a marker
protein were compared by SDS-polyacrylamide gel electrophoresis with
various amounts of AP-1 and AP-2; the amount of the AP-1 and AP-2
µ-chains were quantified by densitometric scanning relative to
the standard. Receptor cytoplasmic domain-GST fusion constructs (2.0 µM) were incubated with AP-2 (50 nM) in 25 mM HEPES, pH 7.5, 50 mM KCl, 1 mM
MgCl2, 1 mg/ml bovine serum albumin, and 0.01% Triton
X-100. After incubation for 1 h at room temperature,
glutathione-Sepharose beads (30 µl of a 50% slurry) were added for
1 h. Beads were then pelleted at low speed and washed three times
in HKE buffer, pH 8.0. Bound proteins were eluted by incubation with
elution buffer for 15 min and separated by 12% SDS-polyacrylamide gel
electrophoresis. After transfer to nitrocellulose, AP-1 and AP-2 were
detected by Western blotting analysis using the anti- Other Methods--
Protein was determined using Bio-Rad reagent
and bovine serum albumin as a standard.
We established a fluorescence-based assay to examine the
interaction of recombinant TIP47 with receptor cytoplasmic domains. For
this purpose, we attached Texas Red to free amino groups present on
bacterially expressed, N-terminally His-tagged TIP47 (TxRed-TIP47). As
shown in Fig. 1, as many as 18 mol of
Texas Red could be incorporated into TIP47. However, at high levels of
dye substitution, a significant amount of fluorescence quenching was
observed, possibly due to protein aggregation. We therefore utilized a
molar ratio of 2:1 (Texas Red:TIP47) for the experiments described
here.
The binding assay was carried out as follows. TxRed-TIP47 was incubated
with the cytoplasmic domains of mannose 6-phosphate receptors, in the
form of GST fusion proteins. Receptor-bound TIP47 was then
collected on glutathione-Sepharose and quantified using a fluorimeter
after elution of the resin with excess glutathione.
Fig. 2 shows that the specificity of
TIP47 binding determined previously using an immunoblot assay (8) can
be recapitulated using the fluorescence-based assay. TIP47 bound to the
CD-MPR cytoplasmic domain in strong preference to the LDL receptor
cytoplasmic domain. Moreover, TIP47 failed to interact with a CD-MPR in
which the FW motif was replaced by two alanine residues. Thus, the
fluorescence assay was well suited to investigate the affinity of the
binding interaction and the selectivity of TIP47 for a variety of
potential transmembrane cargo proteins.
Quantitative Analysis of TIP47-Receptor Cytoplasmic Domain
Interactions
IMPLICATIONS FOR ENDOSOME-TO-TRANS GOLGI NETWORK
TRAFFICKING*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-SNAP (7),
microtubules, cytoplasmic dynein, and a protein named mapmodulin (7)
are all required for the delivery of MPRs from endosomes to the Golgi complex.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP
incorporation suggested incorporation of 2 mol of phosphate/mol of
cytoplasmic domain; under identical conditions, GST was not a substrate
for the kinase.
ex = 596 nm and
em = 611 nm with an
AMINCO Bowman series 2 Luminescence spectrometer (Urbana, IL).
-adaptin
antibody (100:3) or anti-
-adaptin monoclonal antibody (100:2) (Sigma).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
Incorporation of Texas Red dye onto
TIP47. Labeling was carried out as described under "Experimental
Procedures" using increasing concentrations of Texas Red.

View larger version (18K):
[in a new window]
Fig. 2.
Texas Red-labeled TIP47 shows the expected
specificity for binding CD-MPRs. TIP47 binding to GST-cytoplasmic
domain constructs representing wild type CD-MPR (filled
circles), CD-MPR F18A/W19A
(FW
AA) (open diamonds),
CD-MPR Y45A/V48A (YV
AA) (open
circles), or LDL receptor (open
triangles) is shown.
Equilibrium binding constants for TIP47-receptor cytoplasmic domain
interactions were then determined using the fluorescence assay (Fig.
3). These experiments revealed that TIP47
interacts more strongly with the CI-MPR cytoplasmic domain, with an
apparent KD of 1 µM. A weaker
interaction with the CD-MPR cytoplasmic domain (KD = 3 µM) may be due to the possible oligomerization of this
cytoplasmic domain construct (24).
|
We also performed experiments to determine the rates of association and dissociation of TIP47 with both CI-MPR and CD-MPR cytoplasmic domains. TIP47 association was measured by adding the protein to receptor cytoplasmic domains prebound to glutathione-Sepharose. Rapid mixing and separation was achieved by carrying out the incubations in a syringe that could be cleared rapidly by air pressure. These experiments confirmed that binding was complete in 15 min (data not shown).
TIP47 dissociation was measured by forming TIP47-receptor
cytoplasmic domain complexes, collecting them on glutathione-Sepharose, and then washing the samples under continuous flow and monitoring the
amount of TIP47 remaining on the beads as a function of time. From
these experiments, we determined the TIP47 dissociation rate to be
0.9-1.0 × 10
2
min
1. The relatively slow dissociation rate
ensured that the brief wash step for the removal of unbound TIP47 would
result in a minimal loss of MPR-bound TIP47.
TIP47 Binding Specificity--
The specificity of TIP47 binding
was examined by carrying out binding reactions using other
GST-cytoplasmic domain constructs. In this study, we included HIV-Nef,
a 206-residue, myristoylated cytoplasmic protein that enhances the
endocytosis of the CD4 glycoprotein by linking CD4 to the clathrin AP-2
adaptor complex at the plasma membrane (25-27). Nef can also link CD4
to
-COP (28). HIV-1-Nef recruits clathrin adaptors via a dileucine
based signal near its C terminus and
-COP via a diacidic sequence,
also near its C terminus (26, 28). Since Nef binds AP-2 and
-COP, it
was worth checking if it also bound TIP47.
As shown in Fig. 4, fluorescent TIP47
failed to bind the cytoplasmic domains of furin and carboxypeptidase D,
under conditions in which significant binding to the CI-MPR was
detected. Compared with the CI-MPR (KD = 0.8 µM), furin and CPD displayed apparent
KD values of
50 and
70 µM,
respectively. It is hard to imagine that these proteins are ever found
at this high a level in the membranes of mammalian cells.
Similarly, HIV-Nef bound TIP47 with an apparent
KD of 12.2 µM (not shown). Altogether, the lack of interaction of furin and carboxypeptidase D
with TIP47 was unexpected, because these proteins cycle between endosomes and the trans Golgi network.
|
Furin sorting has been shown to be dependent upon the specific phosphorylation of its cytoplasmic domain (29). Moreover, interaction of furin with a key sorting protein named PACS-1 is dependent upon furin phosphorylation (30). Thus, we tested whether phosphorylated furin cytoplasmic domain showed enhanced interaction with TIP47. Fig. 4 shows that the phosphorylated furin cytoplasmic domain did not show any difference in its ability to interact with TIP47 as nonphosphorylated furin cytoplasmic domain.
Another important substrate to test was TGN38. Although the function of this protein is not known, it is a steady-state resident of the trans Golgi network and continually cycles between the cell surface and the TGN (31). Initial experiments suggested strong binding of recombinant GST-TGN38 cytoplasmic domain to Texas Red-labeled TIP47. However, experiments using other fluorescently labeled control proteins strongly suggested that the observed binding was entirely nonspecific, in contrast to the other proteins tested (data not shown). It is important to note that the TGN38 cytoplasmic domain is more difficult to purify than all of the other constructs and can only be eluted from glutathione-Sepharose in the presence of detergent. Also, the TGN38 cytoplasmic domain-GST fusion protein has a pI of 8.9 compared with all of the other constructs, which have predicted pI values of 5.5-6. Thus, we sought an alternative binding assay strategy that would decrease potential nonspecific binding.
We reasoned that unlabeled cytosolic TIP47, present within a mixture of
cytosolic proteins, would provide a physiologically relevant test of
TIP47-TGN38 cytoplasmic domain interaction. Thus, GST-TGN38 cytoplasmic
domain was incubated with cytosolic proteins, and the bound material
was tested for the presence of TIP47 by immunoblotting. As shown in
Fig. 5, only background levels of binding
were observed for cytosolic TIP47 interaction with LDL receptor and
TGN38 cytoplasmic domains. In contrast, significant TIP47 bound to the
CI-MPR cytoplasmic domain under identical conditions. These experiments
show that TIP47 does not interact with the cytoplasmic domain of TGN38
under relatively physiological conditions.
|
Receptor Cytoplasmic Domains Are Functional-- All of the experiments described thus far rely on the proper folding and functionality of the recombinant, GST fusion proteins. To verify that the proteins used in this study were active, we tested their capacities to interact with the clathrin adaptor, AP-2. AP-2 binds to tyrosine-based signals in receptor cytoplasmic domains and mediates their endocytosis via clathrin-coated vesicles (10).
To monitor potential AP-2 association, receptor cytoplasmic domain-GST
fusion constructs were incubated with purified, bovine AP-2; bound AP-2
was then quantified after collection of receptor-AP2 complexes using
glutathione-Sepharose beads followed by immunoblot analysis. Fig.
6A shows an experiment carried
out to validate the assay procedure. As expected, AP-2 failed to bind
GST alone and bound efficiently to the CI-MPR cytoplasmic domain.
Binding was entirely dependent on the presence of a tyrosine-based
motif, because when a CI-MPR construct was employed in which
Tyr24, Tyr26, and Val29 were
converted to alanine, no binding was observed. Lack of binding to this
construct was not due to its misfolding, since it was fully capable of
interacting strongly with TIP47 (Fig. 6B) and AP-1 (data not
shown).
|
We then used this assay to compare the interaction of our various cytoplasmic domain preparations with either TIP47 or AP-2. As shown in Fig. 6C, while the CD-MPR bound significantly more TIP47 than LDL receptor, TGN38, or furin cytoplasmic domains (dark bars), LDL receptor, TGN38, and furin all bound more strongly to AP-2 than the CD-MPR (lighter bars). The cytoplasmic domain of CPD did not bind AP-2 in these experiments (not shown); thus, we cannot rule out the possibility that this construct is misfolded. Nevertheless, our data demonstrate that the cytoplasmic domains of LDL receptor, TGN38, and furin are fully functional in terms of their capacities to interact with cytoplasmic domain-interacting proteins. Moreover, they confirm the high level of selectivity of TIP47 for mannose 6-phosphate receptors.
In these experiments, CI-MPR bound more AP-2 than CD-MPR. It is important to note that GST fusion proteins will dimerize via GST. Moreover, it was possible that in the context of a GST fusion, the smaller, 67-residue CD-MPR cytoplasmic domain is less accessible than the larger, 163-residue, CI-MPR cytoplasmic domain. If true, this would suggest that our estimate for TIP47-CD-MPR interaction might be an underestimate of the true affinity.
To explore this possibility in greater detail, we compared the binding
of AP-1 and AP-2 to both MPR cytoplasmic domains. As shown in Fig.
7, AP-1 actually bound preferentially to
the CD-MPR cytoplasmic domain, whereas AP-2 showed preference for the
CI-MPR cytoplasmic domain. AP-1 also bound to furin but not LDL
receptor (data not shown), as would be expected given previous studies on the sorting of these two proteins (cf. Ref. 29). These
data add confidence to our conclusions that the cytoplasmic domains are
fully folded and have distinct affinities for interactions with
TIP47.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have shown here that TIP47 binds highly selectively to MPR cytoplasmic domains. Recombinant TIP47 binds to the CI-MPR and CD-MPR with apparent KD values of 1 and 3 µM, respectively. Our initial estimates for the affinity of recombinant TIP47 for MPRs are in the same range as that observed for other cargo adapters (cf. Ref. 23) and would be consistent with the intracellular concentrations of these proteins. The KD values are probably more accurate than those we reported previously (8) because of the greater sensitivity and reliability of the assay employed.
Surprising were our findings that TIP47 does not interact with TGN38, furin, or CPD. Like MPRs, these three proteins cycle continuously between the plasma membrane, endosomes, and the Golgi complex. Since only a small percentage of total cell surface proteins are transported back to the Golgi complex (32), it might have been expected that this subset of proteins would share a common route of intracellular transport.
Clues to the existence of multiple pathways for endosome-to-TGN
transport are already numerous and suggest new levels of complexity in
the endosomal system. Shiga toxin (33) and TGN38 (31), for example,
appear to return to the Golgi complex by a process that bypasses late
endosomes entirely and occurs via a compartment referred to as the
"recycling endosome" (Fig. 8). Mallet
and Maxfield (34) showed further that TGN38 and furin are
differentially sorted in endosomes and use distinct routes for their
return to the Golgi. Moreover, it appeared from this work that both
furin and TGN38 were transported from compartments that were distinct from those containing MPRs (34).
|
The data of Mallet and Maxfield (34) fit well with our findings. If TGN38, furin and MPRs are present in different compartments, they must in some way, be differently sorted. When thinking about endosomal sorting, it is important to keep in mind the dynamics of this membrane-bound compartment. It is now fairly well established that endosomes undergo homotypic fusion and also membrane fission; for example, hyperactivity of the Rab5 GTPase can alter the balance between these events for early endocytic compartments (35). Sorting into different endosome classes could be accomplished by protein association with different adapter complexes. As shown in Fig. 8, binding of MPR cytoplasmic domains by TIP47 could lead to their segregation from other cargoes. Subsequent organelle fission could then segregate the two cargo classes into distinct membrane-bound vesicles. Failure to bind TIP47 and/or binding instead to other proteins may very well be responsible for the sorting of furin and TGN38 into different compartments.
Other proteins that are likely to be important for furin sorting include APB-280 (36) and PACS-1 (30), which bind furin in the endocytic pathway. Moreover, as stated earlier, furin phosphorylation is clearly important for its intracellular transport and for its binding to PACS-1 (29, 37, 38). Our observation that furin phosphorylation did not influence TIP47 interaction supports a model in which PACS-1 and TIP47 play distinct roles in the cell. TGN38 is likely to utilize Rab11 for transport from recycling endosomes to the TGN (39), unlike MPR transport, which is dependent upon Rab9 (5, 40). More work will be needed to elucidate the pathway-specific molecules driving these probably distinct intracellular transport pathways.
Taken together, all of these findings suggest that transport from the
endocytic pathway to the biosynthetic pathway is a carefully regulated
process that uses an unexpectedly diverse number of proteins and
possibly also a larger than expected number of transport events. Much
more work will be needed to define the molecular requirements for each
of these pathways and the physiological advantages of this complexity.
A challenge for the future will be to identify any coat proteins with
which TIP47 may interact in its role as a cargo selection device for
MPR trafficking from endosomes to the Golgi complex.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Drs. Gary Thomas, Oleg Varlamov, Lloyd Fricker, Vincent Piguet, Didier Trono, and Sharon Milgram for generous gifts of GST-fusion constructs and Elva Diaz for helping to initiate this project.
| |
FOOTNOTES |
|---|
* This research was supported by a research grant from the National Institutes of Health (DK37336).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a postdoctoral fellowship from the Pharmaceutical
Research and Manufacturers of America Foundation.
§ Supported by a postdoctoral fellowship from the Leukemia Society.
¶ Supported by a postdoctoral fellowship from the Human Frontier Science Program.
To whom correspondence should be addressed. Tel.:
650-723-6169; Fax: 650-723-6783; E-mail:
pfeffer@cmgm.stanford.edu.
Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M001138200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MPR, mannose 6-phosphate receptor; CI-MPR, cation-independent MPR; CD, cation-dependent MPR; CPD, carboxypeptidase D; TGN, trans Golgi network; GST, glutathione S-transferase; LDL, low density lipoprotein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Kornfeld, S., and Mellman, I. (1989) Annu. Rev. Cell Biol. 5, 483-525 |
| 2. | Kornfeld, S. (1992) Annu. Rev. Biochem. 61, 307-330 |
| 3. | Goda, Y., and Pfeffer, S. R. (1988) Cell 55, 309-320 |
| 4. | Itin, C., Rancaño, C., Nakajima, Y., and Pfeffer, S. R. (1997) J. Biol. Chem. 272, 27737-27744 |
| 5. | Lombardi, D., Soldati, T., Riederer, M. A., Goda, Y., Zerial, M., and Pfeffer, S. R. (1993) EMBO J. 12, 677-682 |
| 6. | Díaz, E., Schimmöller, F., and Pfeffer, S. R. (1997) J. Cell Biol. 138, 283-290 |
| 7. | Itin, C., Ulitzur, N., Mühlbauer, B., and Pfeffer, S. R. (1999) Mol. Biol. Cell 10, 2191-2197 |
| 8. | Díaz, E., and Pfeffer, S. R. (1998) Cell 93, 433-443 |
| 9. | Schweizer, A., Kornfeld, S., and Rohrer, J. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14471-14476 |
| 10. | Bonifacino, J. S., and Dell'Angelica, E. C. (1999) J. Cell Biol. 145, 923-926 |
| 11. | Luzio, J., Brake, B., Banting, G., Howell, K., Braghetta, P., and Stanley, K. (1990) Biochem. J. 270, 97-102 |
| 12. | Bos, K., Wraight, C., and Stanley, K. (1993) EMBO J. 12, 2219-2228 |
| 13. | Humphrey, J., Peters, P., Yuan, L., and Bonifacino, J. (1993) J. Cell Biol. 120, 1123-1135 |
| 14. | Wong, S., and Hong, W. (1993) J. Biol. Chem. 268, 22853-22862 |
| 15. | Ponnambalam, S., Rabouille, C., Luzio, P., Nilsson, T., and Warren, G. (1994) J. Cell Biol. 125, 253-268 |
| 16. | Reaves, B., Horn, M., and Banting, G. (1993) Mol. Biol. Cell 4, 93-105 |
| 17. | Molloy, S., Thomas, L., Van Slyke, J., Stenberg, P., and Thomas, G. (1994) EMBO J. 13, 18-33 |
| 18. | Varlamov, O., and Fricker, L. (1998) J. Cell Sci. 111, 877-885 |
| 19. | Bosshart, H., Humphrey, J., Deignan, E., Davidson, J., Drazba, J., Yuan, L., Oorschot, V., Peters, P., and Bonifacino, J. (1994) J. Cell Biol. 126, 1157-1172 |
| 20. | Schaefer, W., Stroh, A., Berghofer, S., Seiler, J., Vey, M., Kruse, M. L., Kern, H., Klenk, H. D., and Garten, W. (1995) EMBO J. 14, 2424-2435 |
| 21. | Takahashi, S., Nakagawa, T., Banno, T., Watanabe, T., Murakami, K., and Nakayama, K. (1995) J. Biol. Chem. 270, 28397-28401 |
| 22. | Keen, J. H., Willingham, M. C., and Pastan, I. H. (1979) Cell 16, 303-312 |
| 23. | Méresse, S., Ludwig, T., Frank, R., and Hoflack, B. (1990) J. Biol. Chem. 265, 18833-13342 |
| 24. | Dahms, N. M., and Kornfeld, S. (1989) J. Biol. Chem. 264, 11458-11467 |
| 25. | LeGall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L., Benarous, R., Heard, J-M., and Schwarz, O. (1998) Immunity 8, 483-495 |
| 26. | Piguet, V., Chen, Y-L., Mangasarian, A., Foti, M, Carpentier, J., and Trono, D. (1998) EMBO J. 17, 2472-2481 |
| 27. | Oldridge, J., and Marsh, M. (1998) Trends Cell Biol. 8, 302-305 |
| 28. | Piguet, V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J-L, and Trono, D (1999) Cell 97, 63-73 |
| 29. | Dittié, A. S., Thomas, L., Thomas, G., and Tooze, S. A. (1997) EMBO J. 16, 4859-4870 |
| 30. | Wan, L., Molloy, S., Thomas, L., Liu, G., Xiang, Y., Rybak, S., and Thomas, G. (1998) Cell 94, 205-216 |
| 31. | Ghosh, R., Mallet, W., Soe, T., McGraw, T., and Maxfield, F. (1998) J. Cell Biol. 142, 923-926 |
| 32. | Duncan, J., and Kornfeld, S. (1988) J. Cell Biol. 106, 617-628 |
| 33. | Mallard, F., Antony, C., Tenza, D., Salamero, J., Goud, B., and Johannes, L. (1998) J. Cell Biol. 143, 973-990 |
| 34. | Mallet, W. G., and Maxfield, F. R. (1999) J. Cell Biol. 146, 345-359 |
| 35. | Bucci, C., Parton, R. G., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B., and Zerial, M. (1992) Cell 70, 715-728 |
| 36. | Liu, G., Thomas, L., Warren, R., Enns, C., Cunningham, C., Hartwig, J., and Thomas, G. (1997) J. Cell Biol. 139, 1719-1733 |
| 37. | Jones, B., Thomas, L., Molloy, S., Thulin, C., Fry, M., Walsh, K., and Thomas, G. (1995) EMBO J. 14, 5869-5883 |
| 38. | Molloy, S., Thomas, L., Kamibayashi, C., Mumby, M., and Thomas, G. (1998) J. Cell Biol. 142, 1399-1411 |
| 39. | Ullrich, O., Reinsch, S., Urbe, S., Zerial, M., and Parton, R. (1996) J. Cell Biol. 135, 913-924 |
| 40. | Riederer, M. A., Soldati, T., Shapiro, A. D., Lin, J., and Pfeffer, S. R. (1994) J. Cell Biol. 125, 573-582 |
| 41. | Phizicky, E. M., and Fields, S. (1995) Microbiol. Rev. 59, 94-123 |
This article has been cited by other articles:
![]() |
V. Popoff, G. A. Mardones, D. Tenza, R. Rojas, C. Lamaze, J. S. Bonifacino, G. Raposo, and L. Johannes The retromer complex and clathrin define an early endosomal retrograde exit site J. Cell Sci., June 15, 2007; 120(12): 2022 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Aivazian, R. L. Serrano, and S. Pfeffer TIP47 is a key effector for Rab9 localization J. Cell Biol., June 19, 2006; 173(6): 917 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Robenek, S. Lorkowski, M. Schnoor, and D. Troyer Spatial Integration of TIP47 and Adipophilin in Macrophage Lipid Bodies J. Biol. Chem., February 18, 2005; 280(7): 5789 - 5794. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Ganley, K. Carroll, L. Bittova, and S. Pfeffer Rab9 GTPase Regulates Late Endosome Size and Requires Effector Interaction for Its Stability Mol. Biol. Cell, December 1, 2004; 15(12): 5420 - 5430. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaguchi, N. Omatsu, S. Matsushita, and T. Osumi CGI-58 Interacts with Perilipin and Is Localized to Lipid Droplets: POSSIBLE INVOLVEMENT OF CGI-58 MISLOCALIZATION IN CHANARIN-DORFMAN SYNDROME J. Biol. Chem., July 16, 2004; 279(29): 30490 - 30497. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Schapiro, T. T. Soe, W. G. Mallet, and F. R. Maxfield Role of Cytoplasmic Domain Serines in Intracellular Trafficking of Furin Mol. Biol. Cell, June 1, 2004; 15(6): 2884 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Arighi, L. M. Hartnell, R. C. Aguilar, C. R. Haft, and J. S. Bonifacino Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor J. Cell Biol., April 12, 2004; 165(1): 123 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Blot, K. Janvier, S. Le Panse, R. Benarous, and C. Berlioz-Torrent Targeting of the Human Immunodeficiency Virus Type 1 Envelope to the trans-Golgi Network through Binding to TIP47 Is Required for Env Incorporation into Virions and Infectivity J. Virol., June 15, 2003; 77(12): 6931 - 6945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hanna, K. Carroll, and S. R. Pfeffer Identification of residues in TIP47 essential for Rab9 binding PNAS, May 28, 2002; 99(11): 7450 - 7454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Barbero, L. Bittova, and S. R. Pfeffer Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells J. Cell Biol., February 4, 2002; 156(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Reddy and M. N.J. Seaman Vps26p, a Component of Retromer, Directs the Interactions of Vps35p in Endosome-to-Golgi Retrieval Mol. Biol. Cell, October 1, 2001; 12(10): 3242 - 3256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Johnson, M. A. Lampson, and T. E. McGraw A Di-Leucine Sequence and a Cluster of Acidic Amino Acids Are Required for Dynamic Retention in the Endosomal Recycling Compartment of Fibroblasts Mol. Biol. Cell, February 1, 2001; 12(2): 367 - 381. [Abstract] [Full Text] |
||||
![]() |
I Miwako, A Yamamoto, T Kitamura, K Nagayama, and M Ohashi Cholesterol requirement for cation-independent mannose 6-phosphate receptor exit from multivesicular late endosomes to the Golgi J. Cell Sci., January 5, 2001; 114(9): 1765 - 1776. [Abstract] [PDF] |
||||
![]() |
P. Barbero, E. Buell, S. Zulley, and S. R. Pfeffer TIP47 Is Not a Component of Lipid Droplets J. Biol. Chem., June 22, 2001; 276(26): 24348 - 24351. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Barbero, L. Bittova, and S. R. Pfeffer Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells J. Cell Biol., February 4, 2002; 156(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||